| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 04/03/2007 | US7199234 Nucleotide sequences coding telomerase reverse transcriptase (TRT) for diagnosing and treating cancers; antiproliferative agents |
| 04/03/2007 | US7199232 Isolated nucleic acid molecules encoding a bacterial uracil transport protein and a bacterial uracil phosphoribosyl-transferase enzyme, cells transformed therewith and uses thereof |
| 04/03/2007 | US7199228 Nucleotide sequences comprising nebularine, hypoxanthine and uracil; antitumor agents; antiproliferative agents; anticarcinogenic agents; antiinflammatory agents |
| 04/03/2007 | US7199225 Stimulating differentiation in growth of osteoblasts and osteoclasts; wound healing of bone fractures and de novo bone formation; osteoporosis; bone cancer treatment; polynucleotide encoding polypeptide; genetic engineering |
| 04/03/2007 | US7199219 Polypeptides derived from vitamin D nuclear receptor, and their uses in particular for screening vitamin D analogues |
| 04/03/2007 | US7199162 Pretreatment before allogenic transplantation of bone marrow or haematopoietic stem cells; may be administered with other chemotherapeutic or immunosuppressive agents; antitumor and anticarcinogenic agents |
| 04/03/2007 | US7199161 Clusianon derivatives; anticarcinogenic, antitumor and viricidal agents; mixture with mitogen-activated protein (MAP) kinase inhibitors |
| 04/03/2007 | US7199152 TNF-α production inhibitor comprising kavalactone as an active ingredient |
| 04/03/2007 | US7199150 Amino alcohol compounds |
| 04/03/2007 | US7199148 Such as (1-Benzyl-2-hydroxy-3-{isobutyl-[2-oxo-3-(1H-pyrrol-2-ylmethylene)-2,3-dihydro-1H-indole-5-sulfonyl]-amino}-propyl)-carbamic acid hexahydro-furo[2,3-b]furan-3-yl ester; multi-drug resistant HIV infections |
| 04/03/2007 | US7199147 Rho kinase inhibitors |
| 04/03/2007 | US7199143 3-[4-(3,6-dihydro-2H-thiopyran-4-yl) phenyl]-]5[1H or 2H-1,2,3-triazol-1 or 2-yl] oxazolidin-2-ones; grampositive bactericides for drug resistant bacteria, especially Staphylococcus, Enterococcus, and Streptococcus |
| 04/03/2007 | US7199142 1-((5-aryl-1,2,4-oxadiazol-3-yl) benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl) pyrrolidine-3-carboxylates as edg receptor agonists |
| 04/03/2007 | US7199140 (bis(Phenoxy or phenylsulfonamido)phenylethyl)pyridyl carboxylic acids, esters or amides; antidiabetic agents; obesity; glucokinase agonists |
| 04/03/2007 | US7199139 Medicinal compositions containing diuretic and insulin resistance-improving agent |
| 04/03/2007 | US7199137 Treatment of neurotraumatic diseases, cancer, chronic neurodegeneration, pain, migraine and cardiac hypertrophy |
| 04/03/2007 | US7199133 Antitumor agenst; thrombosis; arteriosclerosis; cardiovascular disorders; antiinflammatory agents |
| 04/03/2007 | US7199132 For therapy of neurodegenerative disease, psychiatric dysfunction, dopamine dysfunction, cocaine abuse and clinical dysfunction |
| 04/03/2007 | US7199130 Substituted 5,6,6a, 11b-tetrahydro-7-oxa-5-aza-benzo[c]fluorene-6-carboxylic acid compounds as NMDA-antagonists |
| 04/03/2007 | US7199124 Antiinflammatory agents; antiarthritic agents; immunomoderators |
| 04/03/2007 | US7199116 Administering 7-oxo-dehydroepiandrosterone (DHEA) or prodrug incapable of in vivo conversion to testosterone |
| 04/03/2007 | US7199098 Copolymer-1 improvements in compositions of copolymers |
| 04/03/2007 | US7198944 for the treatment of leukemia, tumors, chronic infections, autoimmune disease, fibrotic disorders, wound healing and psoriasis |
| 04/03/2007 | US7198910 Nucleic acid encoding melanin-concentrating hormone receptor |
| 04/03/2007 | US7198790 Growth differentiation factor-5 |
| 04/03/2007 | US7198783 Sensitization of neoplastic cells to radiation therapy with reovirus |
| 04/03/2007 | CA2425539C Crystalline monohydrate, processes for the preparation thereof and the use thereof for preparing a pharmaceutical composition |
| 04/03/2007 | CA2296586C New 2,3-benzodiazepine derivatives |
| 04/03/2007 | CA2294581C Angiogenesis inhibiting 5-substituted-1,2,4-thiadiazolyl derivatives |
| 04/03/2007 | CA2289570C 9-azabicyclo(3.3.1)non-2-ene and nonane derivatives as cholinergic ligands at nicotinic ach receptors |
| 04/03/2007 | CA2288140C Farnesyltransferase inhibiting quinazolinones |
| 04/03/2007 | CA2281918C Oxazolidines as 5-ht2a-antagonists |
| 04/03/2007 | CA2238295C Complementary adenoviral vector systems and cell lines |
| 04/03/2007 | CA2236269C Selective .beta.3 adrenergic agonists |
| 04/03/2007 | CA2205275C Vitamin d3 analogs |
| 04/03/2007 | CA2186601C New combination of a .beta.-receptor blocker and a local anaesthetic |
| 04/03/2007 | CA2180660C Novel piperidine derivatives with paf antagonist activity |
| 04/03/2007 | CA2177578C Preventing and treating elevated intraocular pressure associated with administered or endogenous steroids using non-steroidal cyclooxygenase inhibitors |
| 04/03/2007 | CA2176510C Method for preparing concentrated biologically active silicon compounds |
| 04/03/2007 | CA2149044C Use of dimethylbenzofurans and dimethylbenzopyrans as 5-ht3 antagonists |
| 04/03/2007 | CA2108770C Bmp-9 compositions |
| 03/29/2007 | WO2007035784A1 Vitamin d derivatives for the treatment of type i diabetes |
| 03/29/2007 | WO2007035496A1 Tail variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers |
| 03/29/2007 | WO2007035123A1 Antimutagen |
| 03/29/2007 | WO2007035121A2 Isoflavones for treating mucopolysaccharidoses |
| 03/29/2007 | WO2007034958A1 Anti-angiogenic composition comprising grain-derived component as active ingredient |
| 03/29/2007 | WO2007034924A1 METALLO-β-LACTAMASE INHIBITOR |
| 03/29/2007 | WO2007034917A1 Novel adenine compound |
| 03/29/2007 | WO2007034916A1 Novel adenine compound |
| 03/29/2007 | WO2007034910A1 Medicinal composition for treating bulimia and depression accompanying bulimia |
| 03/29/2007 | WO2007034882A1 Novel adenine compound |
| 03/29/2007 | WO2007034881A1 Novel adenine compound |
| 03/29/2007 | WO2007034852A1 Composition for life extension and method of extending the life |
| 03/29/2007 | WO2007034817A1 Novel adenine compound |
| 03/29/2007 | WO2007034784A1 Ctgf gene expression inhibitor |
| 03/29/2007 | WO2007034778A1 Prophylactic/therapeutic agent for sleep disorder |
| 03/29/2007 | WO2007034753A1 Remedy for angiogenesis-related disease comprising chondromodulin-i as the active ingredient |
| 03/29/2007 | WO2007034200A1 2-aminoalcohols for the treatment of neurodegenerative diseases |
| 03/29/2007 | WO2006086454A3 Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms |
| 03/29/2007 | WO2002056916A8 Compositions and methods for enhanced pharmacological activity through oral and parenteral administration of compositions comprising polypeptide drug substances and other poorly absorbed active ingredients |
| 03/29/2007 | US20070073077 Synthesis of combretastatin A-4 prodrugs and trans-isomers thereof |
| 03/29/2007 | US20070072916 Amino ceramide-like compounds and therapeutic methods of use |
| 03/29/2007 | US20070072875 Anti-inflammatory compositions and methods of use |
| 03/29/2007 | US20070072872 Treating sexual desire disorders with flibanserin |
| 03/29/2007 | US20070072865 Bicyclic piperazine compound and use thereof |
| 03/29/2007 | US20070072849 Tricyclic quinolinone and tricyclic quinoline androgen receptor modulator compounds and methods |
| 03/29/2007 | US20070072826 Compositions and methods for modulation of vascular structure and/or function |
| 03/29/2007 | US20070072820 Gene expression inhibition; sustained release; for reduction of neuronal cell death, inflammation, and scar formation; improves wound healing, skin rejuvenation and thickening |
| 03/29/2007 | US20070072819 Gene expression inhibition; sustained release; for reduction of neuronal cell death, inflammation, and scar formation; improves wound healing, skin rejuvenation and thickening |
| 03/29/2007 | US20070072818 Endothelial growth factors; antiischemic agents; neovascularization |
| 03/29/2007 | US20070072794 Novel genes and proteins encoded thereby |
| 03/29/2007 | US20070072256 Optical molecular sensors for cytochrome p450 activity |
| 03/29/2007 | US20070072236 Novel type II Na/Pi cotransporters and type II Na/Pi cotransporter expression regulatory factors |
| 03/29/2007 | US20070071794 Drugs for treating diabetes |
| 03/29/2007 | US20070071767 Polypeptides used for induction of cytotoxic T lymphocytes or activation of human leukocyte antigens (HLA), administered as anticarcinogenic vaccines; immunology |
| 03/29/2007 | US20070071752 Sphingosine kinase enzyme |
| 03/29/2007 | US20070071730 Stem cells of the islets of langerhans and their use in treating diabetes mellitus |
| 03/29/2007 | DE102005045671A1 Verwendung eines Kollagens xenogenen Ursprungs Use of a collagen xenogenic origin |
| 03/29/2007 | DE10125882B4 Arzneimittel enthaltend Ambroxol, dessen Salze und/oder Prodrugs zusammen mit α-Liponsäure im Rahmen der Behandlung des Diabetes mellitus Medicament comprising ambroxol, its salts and / or prodrugs together with α-lipoic acid in the context of the treatment of diabetes mellitus |
| 03/29/2007 | CA2624420A1 Vitamin d derivatives for the treatment of type i diabetes |
| 03/29/2007 | CA2623092A1 2-aminoalcohols for the treatment of neurodegenerative diseases |
| 03/29/2007 | CA2622523A1 Tail variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers |
| 03/29/2007 | CA2620675A1 Metallo-.beta.-lactamase inhibitors |
| 03/28/2007 | EP1767638A2 Mutation associated with epilepsy |
| 03/28/2007 | EP1767637A1 Mutation associated with epilepsy |
| 03/28/2007 | EP1767634A1 Novel galectin 8 modification protein and use thereof |
| 03/28/2007 | EP1767633A1 Novel polypeptide useful for diagnosis and treatment of cancer |
| 03/28/2007 | EP1767632A2 A method for local administration of synthetic double-stranded oligonucleotides targeting a VEGF receptor |
| 03/28/2007 | EP1767625A1 Activity regulator for interferon producing cell |
| 03/28/2007 | EP1767542A2 HLA-A2. 1 binding peptides and their uses |
| 03/28/2007 | EP1767533A1 N-{(2-(2,6-dioxo(3-piperidyl)-1,3-dioxo-2,3-dihydro-1H-isoindolin-4-yl)methyl}cyclopropylcarboxamide as TNF inhibitor |
| 03/28/2007 | EP1767531A1 Medicinal compositions containing 6-hydroxybenzbromarone or salts thereof |
| 03/28/2007 | EP1767525A1 Guanidino compounds as melanocortin-4 receptor (MC4-R) agonists |
| 03/28/2007 | EP1767217A1 Agent for promoting the recovery from dysfunction after the onset of central neurological disease |
| 03/28/2007 | EP1767215A1 Isoflavones against radiation-induced mortality |
| 03/28/2007 | EP1767200A1 Antiaging agent |
| 03/28/2007 | EP1767195A2 Stable spray-dried protein formulations |
| 03/28/2007 | EP1765997A2 Pharmaceutical composition for modulating the activity of triglyceride hydrolase |
| 03/28/2007 | EP1765776A1 Novel tetrahydrocarbazole derivatives with improved biological action and improved solubility as ligands for g-protein coupled receptors (gpcrs) |
| 03/28/2007 | EP1765385A1 Sustained release vaccine composition |